Researchers say this net loss is unlikely to reverse without state and federal policy changes, including PBM reform.
|Articles|May 20, 2022
News Roundup: May 16 to May 20
Author(s)Miranda Hester
Your weekly roundup of the latest news from Drug Topics®.
Advertisement
What's Going On with the Infant Formula Shortage
Parents are on edge as the formula shortage worsens across the United States. Pediatricians, the AAP, and White House advise on available options.
FDA Authorizes Non-Prescription At-Home Test for COVID-19, Flu, and RSV
The test will be available direct to consumers without a prescription.
All Ages Need Education on Sunscreen
Data from one study showed younger women more likely to use sunscreen than older adults.
More Than 100,000 US Deaths Prevented by Pfizer-BioNTech Vaccine in 2021
The vaccine also prevented nearly 9 million symptomatic cases.
Bimekizumab Fails to Pass FDA Pre-Approval Inspection
UCB announced the FDA issued a CRL that stated that the FDA cannot approve the BLA in its current form.
Advertisement
Related to this article
At the center of the debate are the growing number of manufacturer demands for claims data as a condition of 340B pricing.
Nicholas Rebold, PharmD, MPH, BCIDP, AAHIVP, discusses his team’s and patients’ experiences in a pharmacist-led antiretroviral initiative.
Zaid Fadul, MD, FS, FAAFP, introduces the Nolla Derm app, what it might mean for pharmacists and their patients, and where AI prescribing is headed in the future.
Among a collection of patients across 15 pharmacies, researchers assessed acceptability and satisfaction with pharmacist-led clinical services.
From expert sources and recent data updates to a look at cases amid the ongoing respiratory virus season, this is an updated look at 2026 measles outbreaks in the US.
Zaid Fadul, MD, FS, FAAFP, joins for part 2 to discuss what greater adoption of AI across health care ecosystems might mean for pharmacists, patients, and more.
For pharmacies competing with CVS and relying on Caremark to serve patients, the prospect of those businesses operating under separate ownership is significant.
Advertisement
Advertisement